Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyldiguanide Combined With AI in Metastatic Breast Cancer
NCT01654185Phase 2Completed
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in breast cancer. Started Jul 2012; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01654185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654185.